{
    "clinical_study": {
        "@rank": "80737", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "ziprasidone", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if ziprasidone is safe and effective for the\n      treatment of children and adolescents (ages 10-17) with bipolar I disorder (manic or mixed)."
        }, 
        "brief_title": "Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder", 
        "completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Bipolar Disorder", 
        "condition_browse": {
            "mesh_term": "Bipolar Disorder"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  DSM V criteria for Bipolar I disorder (manic or mixed); age 10 - 17 years.\n\n        Exclusion Criteria:\n\n          -  Imminent risk of suicide or homicide, as judged by the site investigator; any history\n             of serious or unstable medical illness, including risk for QT prolongation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02075047", 
            "org_study_id": "A1281198"
        }, 
        "intervention": [
            {
                "arm_group_label": "1", 
                "description": "Placebo matching the oral ziprasidone capsules of 20,40, 60 and 80 mg in strength. Subjects will be dosed for 4 weeks using a flexible dosing design. Dosing is stratified based on weight, with subjects <45 kg having a target dose range of 60-80 mg/day and subjects >/= 45 kg having a target dose range of 120-180 mg/day.", 
                "intervention_name": "placebo oral capsules", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "ziprasidone", 
                "description": "Oral ziprasidone capsules of 20,40, 60 and 80 mg in strength. Subjects will be dosed for 4 weeks using a flexible dosing design.  Dosing is stratified based on weight, with subjects <45 kg having a target dose range of 60-80 mg/day and subjects >/= 45 kg having a target dose range of 120-180 mg/day.", 
                "intervention_name": "ziprasidone oral capsules", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ziprasidone"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Bipolar I Disorder (current or most recent episode manic)", 
            "Children and adolescents aged 10 to 17 years"
        ], 
        "lastchanged_date": "May 22, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A1281198&StudyName=Efficacy%20and%20Safety%20Trial%20of%20Flexible%20Doses%20of%20Oral%20Ziprasidone%20in%20Children%20and%20Adolescents%20with%20Bipolar%20I%20Disorder%20"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Dothan", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "36303"
                    }, 
                    "name": "Harmonex Neuroscience Research, Inc."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72211"
                    }, 
                    "name": "Arkansas Psychiatric Clinic Clinical Research Trials, P.A."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72211"
                    }, 
                    "name": "Woodland International Research Group Inc."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72211"
                    }, 
                    "name": "Woodland International Research Group, Inc."
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92868"
                    }, 
                    "name": "Neuropsychiatric Research Center of Orange County"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange City", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32763"
                    }, 
                    "name": "Medical Research Group of Central Florida"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30308"
                    }, 
                    "name": "Atlanta Center for Medical Research"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Smyrna", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30080-6315"
                    }, 
                    "name": "Attalla Consultants LLC dba Institute for Behavioral Medicine"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vernon Hills", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60061"
                    }, 
                    "name": "Sleep and Behavioral Medicine Institute"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Flowood", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "39232"
                    }, 
                    "name": "Precise Research Centers"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14618"
                    }, 
                    "name": "Finger Lakes Clinical Research"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27707"
                    }, 
                    "name": "Triangle NeuroPsychiatry"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edmond", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73013"
                    }, 
                    "name": "Paradigm Research Professionals, LLC"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73112"
                    }, 
                    "name": "Sooner Clinical Research"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Chester", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19380"
                    }, 
                    "name": "University Services"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77098"
                    }, 
                    "name": "Houston Clinical Trials, LLC"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 3, Multicenter, Four-Week, Randomized, Double Blind, Placebo Controlled, Parallel Group Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder (Current Or Most Recent Episode Manic)", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "YMRS: an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.", 
            "measure": "Change from Baseline in Young Mania Rating Scale (YMRS) to week 4", 
            "safety_issue": "No", 
            "time_frame": "Week 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02075047"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "CGI-S: 7-point clinician rated scale to assess severity of participant's current illness state; range: 1 (normal - not ill at all) to 7 (among the most extremely ill patients).  Higher score = more affected", 
                "measure": "Clinical Global Impression of Severity (CGI S) score change from baseline.", 
                "safety_issue": "No", 
                "time_frame": "Weeks 1,2,3 and 4"
            }, 
            {
                "description": "CGI-I: 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved), 2 (much improved), or 3 (minimally improved) on the scale.  Higher score = more affected", 
                "measure": "Clinical Global Impression - Improvement (CGI-I) score", 
                "safety_issue": "No", 
                "time_frame": "Weeks 1,2,3 and 4"
            }, 
            {
                "description": "YMRS: an 11-item scale that measures the severity of manic episodes. Four items are rated on a scale from 0 (symptom not present) to 8 (symptom extremely severe). The remaining items are rated on a scale from 0 (symptom not present) to 4 (symptom extremely severe). The YMRS total score ranges from 0 to 60.", 
                "measure": "Change from Baseline in Young Mania Rating Scale (YMRS) at Weeks 1,2 and 3", 
                "safety_issue": "No", 
                "time_frame": "Weeks  1,2 and 3"
            }
        ], 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}